Category: Press Release - Psychedelic Alpha

Introducing Pα+: learn more and subscribe today.

Read more about the article atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit

atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit

Post published:October 6, 2023
Post category:Press Release

Read more about the article Reunion Neuroscience Inc. to Participate in October Investor Conferences

Reunion Neuroscience Inc. to Participate in October Investor Conferences

Post published:October 5, 2023
Post category:Press Release

Read more about the article Clearmind Medicine to Present at the 8th Annual Dawson James Conference on October 12th

Clearmind Medicine to Present at the 8th Annual Dawson James Conference on October 12th

Post published:October 5, 2023
Post category:Press Release

Read more about the article Sunstone Therapies Announces Expansion of Innovative Dyad Study

Sunstone Therapies Announces Expansion of Innovative Dyad Study

Post published:October 3, 2023
Post category:Press Release

Read more about the article Numinus Announces Psychedelic Program for Mental Distress Associated with Chronic and Serious Illness through Cedar Clinical Research

Numinus Announces Psychedelic Program for Mental Distress Associated with Chronic and Serious Illness through Cedar Clinical Research

Post published:October 3, 2023
Post category:Press Release

Read more about the article atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants

atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants

Post published:October 3, 2023
Post category:Press Release

Read more about the article Disposition of Common Shares of Small Pharma Inc.

Disposition of Common Shares of Small Pharma Inc.

Post published:October 3, 2023
Post category:Press Release

Read more about the article GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression

GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression

Post published:September 29, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH CORP. ANNOUNCES NON-BROKERED PRIVATE PLACEMENT UNIT OFFERING LED BY NEGEV CAPITAL

FILAMENT HEALTH CORP. ANNOUNCES NON-BROKERED PRIVATE PLACEMENT UNIT OFFERING LED BY NEGEV CAPITAL

Post published:September 29, 2023
Post category:Press Release

Read more about the article Canadian Veteran Receives Approval for APEX’s Psilocybin Therapy Through Health Canada’s Special Access Program

Canadian Veteran Receives Approval for APEX’s Psilocybin Therapy Through Health Canada’s Special Access Program

Post published:September 27, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.